Free Trial

60 Degrees Pharmaceuticals (SXTP) SEC Filings & 10K Form

60 Degrees Pharmaceuticals logo
$2.40 -0.07 (-2.64%)
Closing price 07/3/2025 01:32 PM Eastern
Extended Trading
$2.44 +0.05 (+2.05%)
As of 07/3/2025 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent 60 Degrees Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/09/2025
4:23 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
7:53 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
XU CHERYL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
2:10 PM
60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SCHEDULE 13G/A
05/14/2025
1:57 PM
60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
Ayrton Capital LLC (Filed by)
Form SCHEDULE 13G
04/09/2025
7:31 AM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2025
11:15 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form EFFECT
02/14/2025
4:21 PM
60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SCHEDULE 13G/A
02/11/2025
4:23 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form D
Notice of Exempt Offering of Securities 
02/11/2025
3:53 PM
60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SCHEDULE 13G
02/06/2025
9:04 AM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 424B5
02/03/2025
3:05 PM
60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SCHEDULE 13G
01/30/2025
4:30 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2025
7:28 AM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 424B5
01/24/2025
3:51 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
MILLER TYRONE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
3:52 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
3:58 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
MILLER TYRONE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
4:00 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:05 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
7:35 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
XU CHERYL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
4:07 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
5:14 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
12:44 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
3:01 PM
60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
Knight Therapeutics Inc (Filed by)
Form SC 13G/A
11/06/2024
4:26 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
2:46 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form DEF 14A
10/08/2024
7:17 AM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
9:56 AM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form PRE 14A
09/30/2024
11:15 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form EFFECT
09/19/2024
3:30 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/11/2024
3:46 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
XU CHERYL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2024
2:59 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
9:29 AM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
11:03 AM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
3:15 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
12:21 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 424B5
07/24/2024
4:05 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 424B5
07/22/2024
10:23 AM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 424B5
07/18/2024
11:15 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form EFFECT
07/16/2024
4:28 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
4:02 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/09/2024
2:37 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
White House to reset Social Security? (Ad)

Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.

And it could have a major impact on how you collect Social Security - Click here to understand what'
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SXTP) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners